Multrys Interactions
There are 143 drugs known to interact with Multrys (copper sulfate / manganese sulfate / selenium / zinc sulfate), along with 4 disease interactions. Of the total drug interactions, 5 are major, 37 are moderate, and 101 are minor.
- View Multrys disease interactions (4)
Medications known to interact with Multrys
Note: Showing generic names only.
A
- abatacept
- abemaciclib
- abrocitinib
- adalimumab
- afamitresgene autoleucel
- alefacept
- alendronate
- anakinra
- anifrolumab
- anti-thymocyte globulin (rabbit)
- avacopan
- azathioprine
B
- baloxavir marboxil
- baricitinib
- basiliximab
- beclomethasone
- belatacept
- belimumab
- betamethasone
- bimekizumab
- blinatumomab
- brodalumab
- budesonide
C
- cabotegravir
- canakinumab
- carbonyl iron
- ceftibuten
- cephalexin
- cephradine
- certolizumab
- cinoxacin
- ciprofloxacin
- cortisone
- crovalimab
- cyclosporine
D
- daclizumab
- danicopan
- deferiprone
- deflazacort
- delafloxacin
- demeclocycline
- deucravacitinib
- dexamethasone
- dimercaprol
- dimethyl fumarate
- diroximel fumarate
- dolutegravir
- dupilumab
E
- eculizumab
- efalizumab
- efgartigimod alfa
- eltrombopag
- elvitegravir
- enoxacin
- etanercept
- etidronate
- everolimus
F
G
H
I
- ibandronate
- imetelstat
- infliximab
- iptacopan
- iron bisglycinate
- iron polysaccharide
- iron protein succinylate
- ixekizumab
L
- leflunomide
- levofloxacin
- lifileucel
- lomefloxacin
- lurbinectedin
- lymphocyte immune globulin, anti-thy (equine)
M
- methylprednisolone
- minocycline
- mirikizumab
- moxifloxacin
- muromonab-cd3
- mycophenolate mofetil
- mycophenolic acid
N
O
P
R
S
- sarecycline
- sarilumab
- satralizumab
- secukinumab
- siltuximab
- sirolimus
- sirolimus topical
- sodium polystyrene sulfonate
- sparfloxacin
- spesolimab
- sutimlimab
T
- tacrolimus
- temsirolimus
- teplizumab
- teriflunomide
- tetracycline
- tildrakizumab
- tiludronate
- tocilizumab
- tofacitinib
- tralokinumab
- triamcinolone
- trientine
- trovafloxacin
U
V
Z
Multrys disease interactions
There are 4 disease interactions with Multrys (copper sulfate / manganese sulfate / selenium / zinc sulfate) which include:
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.